United States-Israel Bilateral Innovation for Research and Development in Health Act of 2025; BIRD Health Act of 2025
Summary
The United States-Israel Bilateral Innovation for Research and Development in Health Act of 2025, also known as the BIRD Health Act of 2025, aims to establish a collaborative research program between the United States and Israel. This program, administered by the BIRD Foundation, will focus on expanding cooperation in healthcare product and service development and delivery. The Act authorizes $10 million annually from 2026 through 2032 for this initiative.
Expected Effects
The Act will likely foster innovation in healthcare technologies through joint research projects and commercialization efforts. It will also strengthen the healthcare ecosystems in both countries by promoting partnerships and technology transfer. The program intends to improve healthcare delivery and address unmet medical needs through collaborative efforts.
Potential Benefits
- Facilitates joint research and development projects between US and Israeli institutions.
- Supports commercialization of innovative healthcare products and services.
- Strengthens health-related ecosystems through US-Israel partnerships.
- Enhances telemedicine infrastructure and digital health cooperation.
- Promotes biological product manufacturing and supply chain resilience.
Potential Disadvantages
- Potential for bureaucratic delays in establishing and implementing the program.
- Risk of inefficient allocation of funds if projects are not properly evaluated.
- Possible challenges in ensuring equitable access to the benefits of the program for all Americans.
- Dependence on the BIRD Foundation for administration, which may introduce biases.
- Limited funding may restrict the scope and impact of the program.
Constitutional Alignment
The Act aligns with the Constitution's broad mandate to "promote the general Welfare" (Preamble). Congress's power to enter into agreements with foreign nations is an inherent aspect of its enumerated powers, particularly related to foreign commerce and national security (Article I, Section 8). The Act does not appear to infringe on any specific constitutional limitations.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).